Monitored the implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Issues related to access to home infusion. Issues related to pharmacy benefit management reforms. Issues related to Most Favored Nation drug pricing.
Source-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 19, 2026
- Income
- $70,000.00
- Expenses
- Not reported
- Registrant
- THE NICKLES GROUP, LLC
- Client
- UCB, INC.
- Filing UUID
- cd0dd44c-dfde-431f-8cc5-5cc3126a481b
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate and international taxes. Monitor OECD negotiations related to Pillar II global minimum tax. Monitored H.R. 591, Defending American Jobs and Investment Act, and H.R. 2423, Unfair Tax Prevention Act, as they relate to multinational corporations. H.R.10431, the US Innovation and Global Competitiveness Act of 2026.
Literal federal measure citations: H.R. 1, H.R. 591, H.R. 2423, H.R.10431
Issues related to medication step therapy. S.864, HELP Copays Act, as it relates to out-of-pocket costs for prescription drugs. Issues related to pharmacy benefit management reforms.
Literal federal measure citations: S.864
Issues related to tariffs.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.